Please provide your email address to receive an email when new articles are posted on . A 53-year-old female nonsmoker presented to an outpatient facility in November 2017 with 6 weeks of progressive ...
CHANCE? >> TONIGHT THERE IS A GROWING PUSH TO ADD ANOTHER WEAPON IN THE FIGHT AGAINST COVID-19. >> HERE TO ANSWER YOUR QUESTIONS IS DR. TODD ELLERIN, CHIEF OF INFECTIOUS DISEASES AT SOUTH SHORE HEALTH ...
The company said there is “reasonable probability” that customers who are immunocompromised could have health complications ...
Neurogenic tumour of the nasal cavity is a rare entity and it is rarer still for it to present with visual problem. We like to report a rare case of solitary nasal neurofibroma, which came to light ...
A 35-year-old female presented to an ENT clinic complaining of rhinitis with mucus hypersecretion, rhinorrhea with serous discharge, tinnitus aurium, diminished sense of smell (anosmia), and loss of ...
What caused a 65-year-old man with poorly controlled hypertension to develop an obstruction in his left nasal cavity 2 years ago? That's what Chia-Hsiang Fu, MD, PhD, of Chang Gung Memorial Hospital ...
A recent study led by Mass General Brigham researchers found that a nasal spray developed to target inflammation in the brain could be used to treat chronic symptoms of traumatic brain injury. A nasal ...
Dr. Todd Ellerin is asked why scientists are now pushing harder to develop a nasal spray version of the COVID-19 vaccine.
Nasal polyps are outgrowths of the nasal mucosa. They are typically round or pear-shaped with a smooth, gelatinous, pale to semitranslucent appearance. Polyps are generally visible in the inferior and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback